Pfizer's experimental cancer drug Sutent is showing promise in late stage clinical trials. While many cancer treatments work by killing the cancer cell as well as healthy tissue, Sutent, which is taken in pill form, is specifically targeted to the cancer itself. The treatment works by simultaneously cutting off blood flow to the tumor, killing cancer cells and inhibiting signals that cause the tumor to spread. It is currently being tested for intestinal cancer.

- read this article [1] from AP

ALSO: The European Medical Agency has approved Pfizer's Revatio for pulmonary arterial hypertension, a rare lung disease. Release [2]